/Zoetis%20Inc%20logo%20on%20phone-by%20viewimage%20via%20Shutterstock.jpg)
Valued at a market capitalization of $54.4 billion, Parsippany, New Jersey-based Zoetis Inc. (ZTS) is a leader in the animal health space and is engaged in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions in the United States and internationally.
Companies with a market cap of $10 billion or more are typically referred to as “large-cap stocks.” Zoetis sits comfortably there, with its market cap exceeding this threshold, reflecting its scale, dominance, and staying power.